Both in Medical Labs
GRAIL vs CareDx
Over the past year GRAL returned +56.4% and CDNA returned +486.4%; their daily moves had a correlation of 0.30.
GRAL +56.4% CDNA +486.4%Growth of $1, one year, split-adjusted
| Metric | GRAL | CDNA |
|---|---|---|
| Price | $140.51 | $86.62 |
| Market cap | $6.28B | $4.55B |
| Today | +0.76% | −2.10% |
| 1 month | +2.3% | +35.8% |
| 6 months | +123.9% | +313.4% |
| Year to date | +64.2% | +359.7% |
| 1 year | — | +486.4% |
| Revenue growth (YoY) | +25.7% | +39.3% |
| Gross margin | −28.1% | 71.1% |
| Net margin | −246.7% | 13.8% |
| P/E (TTM) | — | 35.4× |
| Price / sales | 38.0× | 9.1× |
| Net cash | $861.6M | $250.5M |
| Dividend yield | — | — |
| Volatility (60d) | 96.8% | 62.2% |
| Short % of float | 19.3% | 13.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).